Effectiveness of red clover in alleviating menopausal symptoms: A 12-week randomized, controlled trial

Climacteric

Volumn 18, Issue 4, 2015, Pages 568-573

  Shakeri, F ^a   Taavoni, S ^b,c   Goushegir, A ^b,c   Haghani, H ^b  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Menopause; red clover; symptoms

Indexed keywords

PLACEBO; RED CLOVER EXTRACT; STARCH; PLANT MEDICINAL PRODUCT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG CAPSULE; FEMALE; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE RATING SCALE; OUTCOME ASSESSMENT; PLANT LEAF; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RED CLOVER; SCORING SYSTEM; CLOVER; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECTS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PHYTOTHERAPY; PSYCHOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANT LEAVES; PLANT PREPARATIONS; POSTMENOPAUSE; TREATMENT OUTCOME; TRIFOLIUM;

EID: 84932125339     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.999660     Document Type: Article

References (40)

1. Buckler H. T he menopause transition: endocrine changes and clinical symptoms. J Br Menopause Soc 2005; 11: 61-5
2. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002; 57: 257-75
3. Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-offscore for Menopause Rating Scale (MRS) as a screening tool: A cross-sectional survey among midlife Nepalese women. BMC Women's Health 2011; 11: 2-9
4. Barentsen R, van de Weijer PH, Gend Sv, Foekema H. Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas 2001; 38: 123-8
5. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes 2005; 3: 47
6. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: A systematic review. Climacteric 2001; 4: 58-74
7. Sweetland S, Beral V, Balkwill A, et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012; 10: 2277-86
8. Thunell L, Milsom I, Schmidt J, Mattsson L A. S cientific evidence changes prescribing practice- A comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003. BJOG 2006; 113: 15-20
9. Hammar M L, v an de Weijer P H, Franke H R, Pornel B, von Mauw EM, Nijland EA. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability. BJOG 2007; 114: 1522-9
10. Dornstauder E, Jisa E, Unterrieder I, Krenn L, Kubelka W, Jungbauer A. Estrogenic activity of two standardized red clover extracts (Menoflavon ) intended for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2001; 78: 67-75
11. Roudsari AH, Tahbaz F, Hossein-Nezhad A, Arjmandi B, Larijani B, Kimiagar SM. Assessment of soy phytoestrogens ' effects on bone turnover indicators in menopausal women with osteopenia in Iran: A before and after clinical trial. Nutr J 2005; 4: 30 Booth NL
12. Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: A literature review. Menopause 2006; 13: 251-64
13. Messina M J, Wood C E. S oy isoflavones, estrogen therapy, and breast cancer risk: Analysis and commentary. Nutr J 2008; 7: 17
14. Ewies AA. Phytoestrogens in the management of the menopause: up-to-date. Obstet Gynecol Surv 2002; 75: 306-13
15. Imhof M, Gocan A, Reithmayr F, et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006; 55: 76-81
16. Lipovac M, Chedraui P, Gruenhut C, et al. T he effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecol Endocrinol 2011; 28: 203-7
17. van de Weijer PH, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002; 42: 187-93
18. Schneider H, Heinemann L, Rosemeier H P, PotthoffP, Behre H M. The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric 2000; 3: 59-64
19. Heinemann K, Ruebig A, PotthoffP, et al. The Menopause Rating Scale (MRS): A methodological review. Health Qual Life Outcomes 2004; 2: 45
20. PotthoffP, Heinemann L A, Schneider H P, Rosemeier HP, Hauser GA. The Menopause Rating Scale (MRS II): methodological standardization in the German population [in German]. Zentralbl Gynakol 2000; 122: 280-6
21. Darsareh F, Taavoni S, Joolaee S, Haghani H. E ffect of aromatherapy massage on menopausal symptoms: A randomized placebocontrolled clinical trial. Menopause 2012; 19: 995-9
22. Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54-65. BJOG 2012; 119: 40-50
23. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Ehrlich K. Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: Baseline data from the Herbal Alternatives for Menopause Trial (HALT). Am J Obstet Gynecol 2007; 196:593. e1-7 Waidyasekera
24. H, Wijewardena K, Lindmark G, Naessen T. Menopausal symptoms and quality of life during the menopausal transition in Sri Lankan women. Menopause 2009; 16: 164-70
25. Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: A randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005; 21: 257-64
26. Lipovac M, Chedraui P, Gruenhutc C, Gocanc A, Stammler M, Imhof M. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010; 65: 258-61
27. Coon J T, Pittler M H, Ernst E. T rifolium pratense isoflavones in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine 2007; 14: 153-9
28. Burleson M H, Todd M, Trevathan W R. D aily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women. Menopause 2010; 17: 87-95
29. Chen MN, Lin CC, Liu C. Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review. Climacteric 2014 Dec 1. Epub ahead of press
30. Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2013 Dec 10;12: CD001395
31. Geller SE, Studee L. Soy and red clover for midlife and aging. Climacteric 2006; 9: 245-63
32. del Giorno C, Fonseca A M, Bagnoli V R, Assis J S, Soares JM Jr, Baracat EC. Effects of Trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Rev Assoc Med Bras 2010; 56: 558-62
33. Avis NE, Stellato R, Crawford S, Johannes C, Longcope C. Is there an association between menopause status and sexual functioning? Menopause 2000; 7: 297-309
34. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women ' s Health Across the Nation (SWAN). Menopause 2005; 12: 385-98
35. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001; 74: 456-60
36. Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007; 109: 831-40
37. Auerbach L, Rakus J, Bauer C, et al. Pomegranate seed oil in women with menopausal symptoms: A prospective randomized, placebo-controlled, double-blinded trial. Menopause 2012; 19: 426-32
38. Rodenas S, Rodr? guez-Gil S, Merinero MC, Sanchez-Muniz FJ. Dietary exchange of an olive oil and sunflower oil blend for extra virgin olive oil decreases the estimate cardiovascular risk and LDL and apolipoprotein AII concentrations in postmenopausal women. J Am Coll Nutr 2005; 24: 361-9
39. Ehsanpour S, Salehi K, Zolfaghari B, Bakhtiari S. The effect of red clover on quality of life in post menopausal women. Iran J Nurs Midwifery Res 2012; 17: 34-40
40. Xu X, Keecha S, Harris K S, Wang H J, Murphy P A, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995; 125: 2307-15